Ellington Management Group’s GSK GSK Stock Holding History

Ellington Management Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,760	Closed	-$301K	–	657
2019 Q1	$301K	Buy	+5,760	New	+$288K	0.05%	361
2017 Q3	–	Sell	-7,920	Closed	-$427K	–	710
2017 Q2	$427K	Buy	+7,920	New	+$422K	0.06%	292
2017 Q1	–	Sell	-12,480	Closed	-$601K	–	762
2016 Q4	$601K	Buy	12,480 +5,360	+75%	+$265K	0.09%	180
2016 Q3	$384K	Buy	+7,120	New	+$390K	0.11%	370
2016 Q2	–	Sell	-5,120	Closed	-$260K	–	345
2016 Q1	$260K	Buy	5,120 +480	+10%	+$23.9K	0.11%	273
2015 Q4	$234K	Buy	+4,640	New	+$237K	0.08%	383
2014 Q2	–	Sell	-4,240	Closed	-$283K	–	538
2014 Q1	$283K	Buy	+4,240	New	+$287K	0.08%	380

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Ellington Management Group's GSK Position: Q2 2019 in Review

Ellington Management Group sold out of GSK (GSK) in Q2 2019, closing a stake of 5,760 shares — an estimated $301K sold.

Ellington Management Group first reported a position in GSK in Q1 2014 and held it in 7 quarters. The position peaked at $601K in Q4 2016. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Ellington Management Group reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Ellington Management Group sold 5,760 GSK shares in Q2 2019, an estimated $301K.
Ellington Management Group first reported a position in GSK in Q1 2014 and held it in 7 quarters.
Ellington Management Group's GSK position peaked at $601K in Q4 2016.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Ellington Management Group's 13F filing for Q2 2019, filed 14 Aug 2019.